Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section updated to note that items are automatically filled from PubMed, and the revision tag updated to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe funding/update notice about potential data delays and NIH operations status has been removed from the page.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded the RUXCOVID Lancet Rheumatol 2022 publication citation with full author list and DOI. Removed the Lancet Rheumatol 2024 erratum notice.SummaryDifference0.3%

- Check63 days agoChange DetectedUpdated citation (with erratum) and operating status notice added; older citation and earlier revision removed. The page now references the corrected citation version (v3.2.0) and includes current government operating status information.SummaryDifference3%

- Check70 days agoChange DetectedAdded revision v3.1.0; removed several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while updating version from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.